An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics
Clinical trial NCT00448630 · COMPLETED
Trial details
- NCT number
- NCT00448630
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2007-10-23
- Primary completion
- 2008-07-30
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.